Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Hyemi Shin
Affiliation
Research Institute for Future Medicine, Samsung Medical Center
ORCID
Career Start Year
2018
Papers
13
H Index
8
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
33828082
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma.
Cell Death Dis
2021
31096737
Clinical Targeted Next-Generation sequencing Panels for Detection of Somatic Variants in Gliomas.
Cancer Res Treat
2020
33149237
Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target.
Exp Mol Med
2020
32120790
Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening.
Cancers (Basel)
2020
30735871
Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data.
World Neurosurg
2019
31811117
Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target.
Exp Mol Med
2019
31771104
The Protein Neddylation Inhibitor MLN4924 Suppresses Patient-Derived Glioblastoma Cells via Inhibition of ERK and AKT Signaling.
Cancers (Basel)
2019
29939324
Identification of genomic and molecular traits that present therapeutic vulnerability to HGF-targeted therapy in glioblastoma.
Neuro Oncol
2019
31370279
Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models.
Cancers (Basel)
2019
30773189
Cancer genetic markers according to radiotherapeutic response in patients with primary glioblastoma - Radiogenomic approach for precision medicine.
Radiother Oncol
2019
29464076
Quantitative radiomic profiling of glioblastoma represents transcriptomic expression.
Oncotarget
2018
29573206
Identification of transcriptome signature for predicting clinical response to bevacizumab in recurrent glioblastoma.
Cancer Med
2018
30262818
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy.
Nat Genet
2018
1 - 13 of 13
Column Actions
Search
Recommended Authors
Jeff Liu
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year
2016
Number of shared co-authors
0
Olivia Singh
Princess Margaret Cancer Centre
Career Start Year
2016
Number of shared co-authors
0
Chirayu Chokshi
McMaster University
Career Start Year
2015
Number of shared co-authors
0
Vikas Patil
Princess Margaret Hospital
Career Start Year
2013
Number of shared co-authors
0
Erdogan Pekcan Erkan
University of Helsinki
Career Start Year
2011
Number of shared co-authors
0
Veronique Frattini
Institute for Cancer Genetics, Columbia University Medical Center
Career Start Year
2011
Number of shared co-authors
11
Carl Koschmann
University of Michigan-Ann Arbor
Career Start Year
2010
Number of shared co-authors
0
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year
2010
Number of shared co-authors
3
Maxim Sidorov
California Pacific Medical Center Research Institute
Career Start Year
2009
Number of shared co-authors
0
Qianghu Wang
Center for Global Health, School of Public Health, Nanjing Medical University
Career Start Year
2009
Number of shared co-authors
13
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year
2007
Number of shared co-authors
9
Joanna J Phillips
University of California san francisco
Career Start Year
2006
Number of shared co-authors
7
David Capper
Charite University Medicine Berlin
Career Start Year
2005
Number of shared co-authors
1
Verlene Henry
The MD Anderson Cancer Center
Career Start Year
2005
Number of shared co-authors
1
Anita B Hjelmeland
University of Alabama at Birmingham
Career Start Year
2004
Number of shared co-authors
1
Mario L Suv??
Broad Institute of MIT and Harvard
Career Start Year
2004
Number of shared co-authors
1
Massimo Squatrito
Seve Ballesteros Foundation Brain Tumor group
Career Start Year
2002
Number of shared co-authors
6
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year
1998
Number of shared co-authors
6
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year
1996
Number of shared co-authors
3
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
0
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Career Start Year
1996
Number of shared co-authors
2
Pim J French
Erasmus MC Cancer Institute
Career Start Year
1995
Number of shared co-authors
6
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year
1995
Number of shared co-authors
15
Paul S Mischel
Stanford University
Career Start Year
1994
Number of shared co-authors
1
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Career Start Year
1992
Number of shared co-authors
8
Frank B Furnari
University of California San Diego
Career Start Year
1992
Number of shared co-authors
0
Donald M O'Rourke
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year
1991
Number of shared co-authors
0
Howard A Fine
Meyer Cancer Center
Career Start Year
1990
Number of shared co-authors
5
Howard Colman
Huntsman Cancer Institute, University of Utah
Career Start Year
1990
Number of shared co-authors
2
Kenneth Aldape
National Cancer Institute
Career Start Year
1985
Number of shared co-authors
7
row(s) 1 - 30 of 30
Collaborators
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Co-authored papers
13
Doo-Sik Kong
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
10
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
9
Jung-Il Lee
Gangnam Severance Hospital
Co-authored papers
8
Donggeon Kim
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
7
Harim Koo
Korea University College of Medicine
Co-authored papers
6
Hee Jin Cho
Touro College of Osteopathic Medicine
Co-authored papers
6
Jung Won Choi
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers
5
Jeong-Woo Oh
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
5
Jason K Sa
Korea University, College of Medicine
Co-authored papers
5
Jin-Ku Lee
Seoul National University, College of Medicine
Co-authored papers
5
Seung Won Choi
Samsung Medical Center, Sungkyunkwan University
Co-authored papers
4
Sung Tae Kim
Busan Paik Hospital, Inje University
Co-authored papers
4
Hyun Ju Kang
Genomic Medicine Institute, Medical Research Center, Seoul National University
Co-authored papers
4
Sung Heon Kim
Sungkyunkwan University
Co-authored papers
4
Zhaoqi Liu
University of Chinese Academy of Sciences
Co-authored papers
3
Raul Rabadan
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers
3
Yong Jae Shin
Cancer Stem Cell Research Center, Samsung Biomedical Research Institute
Co-authored papers
3
Mijeong Lee
Kyungpook National University
Co-authored papers
3
Jeongwu Lee
Lerner Research Institute, Cleveland Clinic
Co-authored papers
3
Yun Jee Seo
Institute for Refractory Cancer Research, Samsung Medical Center
Co-authored papers
3
Joon Seol Bae
Research Institute of Future Medicine, Samsung Medical Center
Co-authored papers
2
Hye Won Lee
Yonsei University College of Medicine, Severance Hospital
Co-authored papers
2
Gyu Ha Ryu
Sungkyunkwan University
Co-authored papers
2
In-Hee Lee
Children's Hospital Boston
Co-authored papers
2
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Co-authored papers
2
Hye Jin You
Research Institute, National Cancer Center
Co-authored papers
2
Junhyung Kim
Keimyung University School of Medicine
Co-authored papers
2
In-Hee Lee
Co-authored papers
2
Nayoung K D Kim
Samsung Genome Institute, Samsung Medical Center
Co-authored papers
2
1 - 30